PT Bundamedik Tbk Statistics
PT Bundamedik Tbk (BMHS) Stock Statistics & Valuation Metrics
Total Valuation
PT Bundamedik Tbk has a market cap or net worth of IDR 1.63T. The enterprise value is IDR 2.89T.
- Market Cap
- IDR 1.63T
- Enterprise Value
- IDR 2.89T
Share Statistics
PT Bundamedik Tbk has 8,603,416,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,603,416,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PT Bundamedik Tbk’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 2.00%.
- Return on Equity (ROE)
- 0.01
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 2.00%
- Return on Capital Employed (ROCE)
- 0.04
- Revenue Per Employee
- 902.37M
- Profits Per Employee
- 6.94M
- Employee Count
- 1,789
- Asset Turnover
- 0.40
- Inventory Turnover
- 19.20
Valuation Ratios
The current PE Ratio of PT Bundamedik Tbk is -1500.82. PT Bundamedik Tbk’s PEG ratio is 12.40.
- PE Ratio
- -1500.82
- PS Ratio
- 0.97
- PB Ratio
- 0.82
- Price to FCF
- -21.99
- Price to Operating Cash Flow
- 7.21
- PEG Ratio
- 12.40
Income Statement
In the last 12 months, PT Bundamedik Tbk had revenue of 1.61T and earned 12.42B in profits. Earnings per share was 1.66.
- Revenue
- 1.61T
- Gross Profit
- 623.09B
- Operating Income
- 115.29B
- Pretax Income
- 45.28B
- Net Income
- 12.42B
- EBITDA
- 239.90B
- Earnings Per Share (EPS)
- 1.66
Cash Flow
In the last 12 months, operating cash flow was 219.52B and capital expenditures -291.50B, giving a free cash flow of -71.98B billion.
- Operating Cash Flow
- 219.52B
- Free Cash Flow
- -71.98B
- Free Cash Flow per Share
- -8.37
Dividends & Yields
PT Bundamedik Tbk pays an annual dividend of ―, resulting in a dividend yield of 0.54%
- Dividend Per Share
- ―
- Dividend Yield
- 0.54%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4.55%
- Earnings Yield
- -0.07%
Stock Price Statistics
- Beta
- 0.36
- 52-Week Price Change
- 23.38%
- 50-Day Moving Average
- 197.56
- 200-Day Moving Average
- 187.82
- Relative Strength Index (RSI)
- 34.59
- Average Volume (3m)
- 996.92K
Important Dates
PT Bundamedik Tbk upcoming earnings date is Apr 08, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 02, 2026
- Next Earnings Date
- Apr 08, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Bundamedik Tbk as a current ratio of 1.62, with Debt / Equity ratio of 69.53%
- Current Ratio
- 1.62
- Quick Ratio
- 1.55
- Debt to Market Cap
- 0.86
- Net Debt to EBITDA
- 2.21
- Interest Coverage Ratio
- 1.71
Taxes
In the past 12 months, PT Bundamedik Tbk has paid 15.61B in taxes.
- Income Tax
- 15.61B
- Effective Tax Rate
- 0.34
Enterprise Valuation
PT Bundamedik Tbk EV to EBITDA ratio is 14.25, with an EV/FCF ratio of -39.60.
- EV to Sales
- 1.75
- EV to EBITDA
- 14.25
- EV to Free Cash Flow
- -39.60
- EV to Operating Cash Flow
- 12.98
Balance Sheet
PT Bundamedik Tbk has IDR 237.22B in cash and marketable securities with IDR 1.50T in debt, giving a net cash position of -IDR 1.26T billion.
- Cash & Marketable Securities
- IDR 237.22B
- Total Debt
- IDR 1.50T
- Net Cash
- -IDR 1.26T
- Net Cash Per Share
- -IDR 146.50
- Tangible Book Value Per Share
- IDR 265.82
Margins
Gross margin is 41.28%, with operating margin of 6.94%, and net profit margin of -0.07%.
- Gross Margin
- 41.28%
- Operating Margin
- 6.94%
- Pretax Margin
- 0.80%
- Net Profit Margin
- -0.07%
- EBITDA Margin
- 12.31%
- EBIT Margin
- 5.30%
Analyst Forecast
The average price target for PT Bundamedik Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 6.06%
- EPS Growth Forecast
- -60.97%
